ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
8,009.30
-0.10%
S&P ASX All Technology
3,167.40
0.08%
Brent Oil
83.975
-0.43%
US Dollar vs AUD
1.48398
0.36%
Bitcoin
63,746.11
-1.70%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Delcath Systems Inc (DCTH)

  7. Delcath Systems Inc (DCTH) News

DCTH

Delcath Systems (DCTH)

Delcath Systems Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DCTH
DateTimeSourceHeadlineSymbolCompany
12/12/202309:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
08/12/202301:00PR Newswire (US)Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma ResearchNASDAQ:DCTHDelcath Systems Inc
29/11/202308:53Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DCTHDelcath Systems Inc
22/11/202303:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
21/11/202323:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
21/11/202308:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
21/11/202308:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
16/11/202309:00PR Newswire (US)Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DCTHDelcath Systems Inc
14/11/202308:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DCTHDelcath Systems Inc
14/11/202308:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
14/11/202308:05PR Newswire (US)Delcath Systems Reports Third Quarter 2023 Results and Provides Business UpdateNASDAQ:DCTHDelcath Systems Inc
07/11/202308:30PR Newswire (US)Delcath Systems to Host Third Quarter 2023 Results CallNASDAQ:DCTHDelcath Systems Inc
18/10/202307:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
16/10/202323:30PR Newswire (US)Delcath Systems Announces a Comparative Study of Chemosat and SIRT Published in the Journal CancersNASDAQ:DCTHDelcath Systems Inc
10/10/202323:30PR Newswire (US)Delcath Systems to Participate in the Lytham Partners Fall 2023 Investor ConferenceNASDAQ:DCTHDelcath Systems Inc
03/10/202323:30PR Newswire (US)Delcath Systems to Participate at the Roth MKM 2023 Healthcare Opportunities Conference on October 12, 2023NASDAQ:DCTHDelcath Systems Inc
28/09/202306:05PR Newswire (US)Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DCTHDelcath Systems Inc
11/09/202322:00PR Newswire (US)A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual MeetingNASDAQ:DCTHDelcath Systems Inc
07/09/202306:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
06/09/202306:00PR Newswire (US)Delcath Systems to Participate at the H.C. Wainwright 25th Annual Investor Conference on September 12 and 13, 2023NASDAQ:DCTHDelcath Systems Inc
02/09/202306:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DCTHDelcath Systems Inc
02/09/202304:07PR Newswire (US)Delcath Systems, Inc. Announces Additional $35 Million in Funding Tied to the FDA Approval of HEPZATO KIT™NASDAQ:DCTHDelcath Systems Inc
29/08/202322:00PR Newswire (US)Delcath Systems Announces an Independent Investigator Presentation at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual MeetingNASDAQ:DCTHDelcath Systems Inc
24/08/202301:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
23/08/202308:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
22/08/202302:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DCTHDelcath Systems Inc
17/08/202306:30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:DCTHDelcath Systems Inc
15/08/202321:14IH Market NewsTuesday’s Wall Street Highlights: Delcath Systems, Getty Images, Home Depot, Berkshire Hathaway, and moreNASDAQ:DCTHDelcath Systems Inc
15/08/202320:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DCTHDelcath Systems Inc
15/08/202311:10PR Newswire (US)Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal MelanomaNASDAQ:DCTHDelcath Systems Inc
 Showing the most relevant articles for your search:NASDAQ:DCTH

Your Recent History

ASX
FMG
Fortescue
ASX
WBC
Westpac Banking
NASDAQ
TSLA
Tesla
FX
AUDCAD
AUD vs CAD
NASDAQ
NVDA
NVIDIA
NYSE
MCD
McDonalds
ASX
WPL
Woodside Petroleum
ASX
AMP
AMP
ASX
MQG
Macquarie
NASDAQ
MSFT
Microsoft
ASX
CSL
CSL
FX
AUDUSD
AUD vs US Dollar
ASX
NCM
Newcrest Mining
FTSE
UKX
FTSE 100
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved